Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Hematopoiesis and thymic apoptosis are not affected by the loss of Cdk2

Berthet, Cyril ; Rodriguez-Galan, Maria Cecilia ; Hodge, Deborah L. ; Gooya, John ; Pascal, Véronique ; Young, Howard A. ; Keller, Jonathan ; Bosselut, Remy and Kaldis, Philipp LU orcid (2007) In Molecular and Cellular Biology 27(14). p.5079-5089
Abstract

Cell cycle regulation is essential for proper homeostasis of hematopoietic cells. Cdk2 is a major regulator of S phase entry, is activated by mitogenic cytokines, and has been suggested to be involved in antigen-induced apoptosis of T lymphocytes. The role of Cdk2 in hematopoietic cells and apoptosis in vivo has not yet been addressed. To determine whether Cdk2 plays a role in these cells, we performed multiple analyses of bone marrow cells, thymocytes, and splenocytes from Cdk2 knockout mice. We found that Cdk2 is not required in vivo to induce apoptosis in lymphocytes, a result that differs from previous pharmacological in vitro studies. Furthermore, thymocyte maturation was not affected by the lack of Cdk2. We then analyzed the... (More)

Cell cycle regulation is essential for proper homeostasis of hematopoietic cells. Cdk2 is a major regulator of S phase entry, is activated by mitogenic cytokines, and has been suggested to be involved in antigen-induced apoptosis of T lymphocytes. The role of Cdk2 in hematopoietic cells and apoptosis in vivo has not yet been addressed. To determine whether Cdk2 plays a role in these cells, we performed multiple analyses of bone marrow cells, thymocytes, and splenocytes from Cdk2 knockout mice. We found that Cdk2 is not required in vivo to induce apoptosis in lymphocytes, a result that differs from previous pharmacological in vitro studies. Furthermore, thymocyte maturation was not affected by the lack of Cdk2. We then analyzed the hematopoietic stem cell compartment and found similar proportions of stem cells and progenitors in Cdk2-/- and wild-type animals. Knockouts of Cdk2 inhibitors (p21, p27) affect stem cell renewal, but a competitive graft experiment indicated that renewal and multilineage differentiation are normal in the absence of Cdk2. Finally, we stimulated T lymphocytes or macrophages to induce proliferation and observed normal reactivation of Cdk2-/- quiescent cells. Our results indicate that Cdk2 is not required for proliferation and differentiation of hematopoietic cells in vivo, although in vitro analyses consider Cdk2 to be a major player in proliferation and apoptosis in these cells and a potential target for therapy.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; and
publishing date
type
Contribution to journal
publication status
published
in
Molecular and Cellular Biology
volume
27
issue
14
pages
5079 - 5089
publisher
American Society for Microbiology
external identifiers
  • pmid:17485443
  • scopus:34447517654
ISSN
0270-7306
DOI
10.1128/MCB.00029-07
language
English
LU publication?
no
id
3e2b51b8-bcbf-4eb9-8747-8785203866c1
date added to LUP
2019-09-18 14:16:28
date last changed
2024-01-01 20:39:52
@article{3e2b51b8-bcbf-4eb9-8747-8785203866c1,
  abstract     = {{<p>Cell cycle regulation is essential for proper homeostasis of hematopoietic cells. Cdk2 is a major regulator of S phase entry, is activated by mitogenic cytokines, and has been suggested to be involved in antigen-induced apoptosis of T lymphocytes. The role of Cdk2 in hematopoietic cells and apoptosis in vivo has not yet been addressed. To determine whether Cdk2 plays a role in these cells, we performed multiple analyses of bone marrow cells, thymocytes, and splenocytes from Cdk2 knockout mice. We found that Cdk2 is not required in vivo to induce apoptosis in lymphocytes, a result that differs from previous pharmacological in vitro studies. Furthermore, thymocyte maturation was not affected by the lack of Cdk2. We then analyzed the hematopoietic stem cell compartment and found similar proportions of stem cells and progenitors in Cdk2<sup>-/-</sup> and wild-type animals. Knockouts of Cdk2 inhibitors (p21, p27) affect stem cell renewal, but a competitive graft experiment indicated that renewal and multilineage differentiation are normal in the absence of Cdk2. Finally, we stimulated T lymphocytes or macrophages to induce proliferation and observed normal reactivation of Cdk2<sup>-/-</sup> quiescent cells. Our results indicate that Cdk2 is not required for proliferation and differentiation of hematopoietic cells in vivo, although in vitro analyses consider Cdk2 to be a major player in proliferation and apoptosis in these cells and a potential target for therapy.</p>}},
  author       = {{Berthet, Cyril and Rodriguez-Galan, Maria Cecilia and Hodge, Deborah L. and Gooya, John and Pascal, Véronique and Young, Howard A. and Keller, Jonathan and Bosselut, Remy and Kaldis, Philipp}},
  issn         = {{0270-7306}},
  language     = {{eng}},
  month        = {{07}},
  number       = {{14}},
  pages        = {{5079--5089}},
  publisher    = {{American Society for Microbiology}},
  series       = {{Molecular and Cellular Biology}},
  title        = {{Hematopoiesis and thymic apoptosis are not affected by the loss of Cdk2}},
  url          = {{http://dx.doi.org/10.1128/MCB.00029-07}},
  doi          = {{10.1128/MCB.00029-07}},
  volume       = {{27}},
  year         = {{2007}},
}